Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
14.05 EUR | +2.55% | +5.90% | -34.16% |
Apr. 18 | Evotec, Variant Bio Team Up to Develop Treatment for Fibrosis | MT |
Apr. 18 | Evotec, Variant Bio Launch Partnership to Develop Treatments for Fibrosis | MT |
Sales 2023 * | 780M 830M | Sales 2024 * | 919M 979M | Capitalization | 2.43B 2.59B |
---|---|---|---|---|---|
Net income 2023 * | -54M -57.51M | Net income 2024 * | 31M 33.02M | EV / Sales 2023 * | 3.06 x |
Net cash position 2023 * | 46.3M 49.32M | Net cash position 2024 * | 37M 39.41M | EV / Sales 2024 * | 2.6 x |
P/E ratio 2023 * |
-45.1
x | P/E ratio 2024 * |
75.4
x | Employees | 5,086 |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 90.64% |
Latest transcript on Evotec SE
1 day | +0.69% | ||
1 week | -0.58% | ||
Current month | -5.32% | ||
1 month | +0.55% | ||
3 months | -10.34% | ||
6 months | -19.39% | ||
Current year | -35.62% |
Managers | Title | Age | Since |
---|---|---|---|
Mario Polywka
CEO | Chief Executive Officer | 61 | 19-06-18 |
Laetitia Rouxel
DFI | Director of Finance/CFO | 51 | 23-02-06 |
Craig Johnstone
COO | Chief Operating Officer | 54 | 12-04-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Mario Polywka
CEO | Chief Executive Officer | 61 | 19-06-18 |
Roland Sackers
BRD | Director/Board Member | 56 | 19-06-18 |
Chairman | 63 | 14-06-16 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
2.68% | 17 M€ | -.--% | - | |
2.59% | 202 M€ | -.--% | ||
0.21% | 79 M€ | -.--% | ||
0.15% | 2 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
24-04-23 | 14.01 | +2.26% | 202 417 |
24-04-22 | 13.7 | +3.32% | 725,516 |
24-04-19 | 13.26 | -1.41% | 673,258 |
24-04-18 | 13.45 | +1.82% | 694,213 |
24-04-17 | 13.21 | -0.15% | 617,970 |
Delayed Quote Xetra, April 22, 2024 at 11:40 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-35.62% | 2.59B | |
-0.02% | 42.11B | |
+43.29% | 40.08B | |
+5.04% | 40B | |
-11.32% | 26.87B | |
+5.25% | 24.58B | |
-23.83% | 18.44B | |
-1.62% | 11.94B | |
+22.75% | 11.66B | |
+6.44% | 11.01B |
- Stock Market
- Equities
- EVT Stock